1
Trabalhos Publicados
• Gomes d'Oliveira JJ, Parreira AS, Mateus LM, Costa Santos JM,
Fajardo JM, Nascimento Monteiro JM, Abecasis M, Carneiro de
Moura M, Geraldes MJ, Parreira F, Ducla Soares A. Tratamento de
ataque (indução) da leucemia aguda. Experiência de um ano da
Unidade de Cuidados Intensivos de Hematologia do Hospital
Universitário de Santa Maria. O Médico 1977; 82 : 189.
• Maraninchi D, Abecasis M, Gastaut JA, Sebahoun G, Cahn Y,
Novakovitch G, Carcassone Y.High dose melphalan and autologous
bone marrow transplant for relapsed acute leukaemia. Cancer
Chemotherap Pharmacol. 1983; 10:109.
• Maraninchi D, Abecasis M, Gastaut JA, Hervé P, Sebahoun G, Flesch
M, Blanc AP, Carcassone Y. High dose melphalan with autologous
bone marrow rescue for the treatment of advanced adult solid
tumours. Cancer Treat. Rep. 1984; 68:471.
• Maraninchi D, Gastaut JA, Hervé P, Abecasis M, Flesch M, Mascret
B, Sebahoun G, Blanc AP, Domingues C, Carcassone Y. High dose
melphalan and autologous marrow transplantation in adult solid
tumours: clinical responses and preliminary evaluation of different
strategies. In: Verhoef (ed.) Bone Marrow Transplantation for Solid
Tumours. Amesterdam: Elsevier North-Holland Biomedical Press,
1984:387.
• Abecasis M, Dinis da Gama A, Barbosa J, Macedo M, Mineiro J,
Nunes S, Pedro M, Afonso J.O cateter venoso central tipo Hickman
para o acesso vascular em doentes oncológicos. Acta Med. Port
1985; 6:149.
• Abecasis M. Transplantação de medula óssea: perspectivas actuais.
Acta Med. Port.1989, II, suppl. 2:16.
• Sousa A, Simões J, Coelho R, Junior E, Pais MJ, Novais L, Ribeiro O,
Sampaio J, Lebre L, Arez L, Branco H, Barreto L, Abecasis M.
Linfomas não Hodgkin. Revisão de 28 casos. O Médico 1990; 123:7.
2
• Sousa A, Simões J, Boquinhas JM, Arez L, Gonçalves M, Novais L,
Pais MJ, Ribeiro O, Lebre L, Sampaio J, Branco H, Barreto L, Coelho
R, Junior E, Abecasis M. Mieloma multiplo. Revisão de 25 casos. O
Médico 1990; 123:445.
• Abecasis M. Complicações pouco habituais da TMO. Experiência da
UTM do IPOFG, Lisboa. Acta Med. Port. 1991; 4, supl.1 (I):37.
• Romeiras M, Rodrigues AS, Machado A, Jorge L, Nolasco I,
Abecasis M. Relative toxicity of two different conditioning regimens in
patients undergoing allogeneic bone marrow transplantation. Bone
Marrow Transplant 1991,7 suppl 2: 133.
• Abecasis M.Transplantação autóloga de medula óssea (editorial).
Acta Med.Port. 1992; 5:95.
• Abecasis M,Nolasco I, Gonçalves AC, Rodrigues AS, Coelho
R. Successful third bone marrow transplantation for severe aplastic
anemia: possible in vivo synergism of granulocyte-macrophagecolony-stimulating factor and erythropoietin In: Freund M, Link H,
Schmidt K, Welte K (eds). Cytokines in Hematology, Oncology and
AIDS II. Berlin: Springer Verlag, 1992:565.
• Abecasis M.Infección en Pacientes Transplantados. In: Borrasca A,
Pinango C, Guerra C,Parreira A, Pavlovsky S, Arguelles G, San
Miguel J (eds). Enciclopédia Ibero Americana de Hematologia,
Salamanca, 1992; Volume II:758.
• Coelho R, Cunha I, Nolasco I, Machado A, Abecasis M. Transplante
de medula óssea com incompatibilidade ABO major. Experiência da
UTM do Centro de Lisboa do IPOFG. Acta Med. Port. 1993; 6:79.
• Abecasis M, Passos MJ. Combined use of erytropoietin and
granulocyte- macrophage-colony-stimulating factor in patient
undergoing bone marrow transplantation. Preliminary results of a pilot
study. In: Baeur C, Koch K M, Scigalla P, Wieczorek L (eds).
Erythropoietin, Molecular Physiology and Clinical Applications. New
York: Marcel Dekker, 1993: 349.
• Abecasis M. Factores de crescimento hematopoiético em
transplantação de medula óssea. Oncologia Clínica 1993;1:38.
3
• Barquinero J, Witherspoon R, Sanders J, Horowitz M, Montuoro A,
Patton D, Bacigalupo A, Abecasis M M , Miale T, Rozman C, Bryant
E, Storb R. Allogeneic marrow grafts with congenital chromosomal
abnormalities in marrow cells. Br J Haemat 1995; 90:595.
• Abecasis M, Machado A, Boavida G, Silva MG, Lucio P, Ambrosio A,
Jorge ML. Haploidentical cord blood transplant contaminated with
maternal T cells in a patient with advanced leukaemia. Bone Marrow
Transplant 1996; 17:891.
• Abecasis M.Infecção por CMV em transplantação de medula óssea.
In: Infecções por CMV: perpectivas actuais. Coimbra 1996, pp 27-37.
• Abecasis M.Guimarães A, Machado A. Placental blood
transplantation (letter). N Engl J Med 1997; 336: 69.
• Rowlings PA, Przepiorka D, Klein J, Gale RP, Passweg J, HensleeDowney PJ, Cahn JY, Calderwood S, Gratwhol A, Socié G, M M
Abecasis,Sobocinski K, Zhang MJ, Horowitz MM. IBMTR severity
index for grading acute graft-versus-host disease: retrospective
comparison with Glucksberg grade. Br J Haemat 1997; 97: 855.
• Guimarães A, Machado A, Carvalho S, Alaiz H, Vieira L, Abecasis M.
Relapsed chronic myeloid leukemia in accelerated phase 10 years
after allogeneic bone marrow transplantation: full chimera
reconversion with donor peripheral blood stem cells infusion. Bone
Marrow Transplant 1998; 22: 595.
• Abecasis MM, Guimarães A, Machado A, Vieira L, Boavida G, Jorge
M. PBPC as an alternative cell therapy for post-transplant relapse in
CML. Bone Marrow Transplant 1998; 22: 613.
• Abecasis MM.Infecções fúngicas invasivas em doentes submetidos a
transplantação alogénica de medula óssea. Rev Port. D. Infecciosas
1998; 21: 96.
• Abecasis MM,Conceição Silva JP, Ferreira I, Guimarães A, Machado
A. Defibrotide as salvage therapy for refractory veno-occlusive
disease of the liver complicating allogeneic bone marrow
transplantation. Bone Marrow Transplant 1999; 23:843.
4
• Wijker M, Morgan NV, Herterich S, van Berkel CGM, Tipping AJ,
Schindler d, Gille JJP, Pals G, Savino M, Altay C, Mohan SP, Dokal I,
Cavenagh J, Marsh J, Van Weel M, Ortega JJ, Schuler D,
Samochatova E, Karwacki M, Bekassy A, Abecasis M, Ebell W, Kwee
ML, Gibson RA, Gluckman E, Arwert F, Joenje H, Savoia A, Hoehn H,
Pronk JC, Mathew CG. Heterogeneous spectrum of mutations in the
Fanconi anemia group A gene. Europ. J. Human Genetics 1999;7: 52.
• Locatelli F, Rocha V, Chastang C, Arcese W, Michel G, Abecasis M,
Messina C, Ortega J, Badell-Serra I, Plouvier E, Souillet G, Jouet JP,
Pasquini R, Ferreira E, Garnier F, Gluckman E. Factors associated
with outcome after cord blood transplantation in children with acute
leukemia. Blood 1999 ; 93: 3662.
• Rocha V, Wagner J, Sobocinski KA, Klein JP, Zhang MJ, Horowitz M,
Gluckman E, Abecasis M Bolwell BJ, Cairo MS, Carabasi MH, Cowan
MH, Cowan M, Gale RP, Hale G, Harris R, Henslee-Downey J, Hows
J, Shunichi K, Kernan N, Kurtzberg, Lister J, Locatelli F, Michel G,
Nagler A, Ortega J, Pasquini R, Stepaniak TR, Ringdén O, Souillet G,
Trigg ME, Vowels MR, Wingard JR, Yu LC. Comparison of graft
versus host disease in children transplanted with HLA-identical sibling
umbilical cord blood versus HLA-identical sibling bone marrow. N Engl
J Med 2000; 342:1846.
• Centeno-Lima S, Lacerda JM, Carmo JA, Abecasis M, Casimiro C,
Exposto F. Follow-up of anti-Aspergilus IgG and IgA antibodies in
bone marrow transplanted patients with invasive aspergillosis. J Clin
Lab Anal 2002; 16:156.
• Nunes R, Passos-Coelho JL, Miranda N, Nave M, Leal da Costa
F, Abecasis M. Reversible acute renal failure following single
administration of fludarabine. Bone Marrow Transplant 2004; 33:
671.
• Gluckman E, Rocha V, Arcese W, Michel G, Sanz G, Chan KW,
Takahashi TA, Ortega J, Filipovich A, Locatelli F, Asano S, Fagioli F,
Vowels M, Sirvent A, Laporte JP, Tiedemann K, Amadori
S, Abecassis M, Bordigoni P, Diez B, Shaw PJ, Vora A, Caniglia M,
Garnier F, Ionescu I, Garcia J, Koegler G, Rebulla P, Chevret
S. Factors associated with outcomes of unrelated cord blood
5
transplantation: guidelines for donor choice. Exp Hematol 2004; 32:
397.
• Silva MG, Ferreira Neto L, Guimaraes A, Machado A, Parreira
A, Abecasis M. Long-term follow-up of lymphocyte populations and
cellular cytokine production in patients with chronic graft-versus-hst
disease treated with extracorporeal photopheresis. Haematologica
2005, 90: 565.
• Passos-Coelho JL, Sebastião M. Gameiro P, Reichert A, Vieira L,
Ferreira I, Miranda N, Guimarães A, Leal da Costa F, Abecasis
M. Congenital amegakaryocytic thrombocytopenia – report of a new
c-mpl gene missense mutation. Am J Hematol 2007, 82: 240.
• Abecasis M. A contribuição do hematologista para o tratamento de
vitimas de exposição a radiações ionizantes. Radioprotecção 2007,
2: 101.
• Lee SJ, Kukreja M, Wang T, Giralt SA, Szer J, Arora M, Woolfrey
AE, Cervantes F, Champlin RE, Gale RP, Halter J, Keating A, Marks
DI, McCarthy PL, Olavarria E, Stadtmauer EA, Abecasis M, Gupta V,
Khoury HJ, George B, Hale GA, Liesveld JL, Rizzieri DA, Antin JH,
Bolwell BJ, Carabasi MH, Copelan E, Ilhan O, Litzow MR, Schouten
HC, Zander AR, Horowitz MM, Maziarz RT. Impact of prior imatinib
mesylate on the outcome of hematopoietic cell transplantation for
chronic myeloid leukemia. Blood. 2008;112:3500-7.
• Lagresle-Peyrou C, Six EM, Picard C, Rieux-Laucat F, Michel V,
Didati A, Demerens-de Chappedelaine C, Morillon E, Valensi F,
Simon-Stoos KL, Mullikin JC, Noroski LM, Besse C, Wulffraat NM,
Ferster A, Abecasis MM, Calvo F, Petit C, Candotti F, Abel L, Fischer
A, Cavazzana-Calvo M. Human adenylate kinase 2 deficiency
causes a profound hematopoietic defect associated with
sensorineural deafness. Nat Genet 2009, 41: 106.
• Temtem M, Silva LM, Andrade PZ, Dos Santos F, Da Silva C, Cabral
JMS, Abecasis MM, Aguiar-Ricardo A. Supercritical CO2 generating
chitosan devices with controlled morphology. Potential application for
drug delivery and mesenchymal stem cell culture. J Supercritical
Fluids, 2009,48: 269.
6
• Abecasis M.Utilização de células mesenquimatosas pluripotentes em
transplantação de medula óssea. ABO 2009, 40: 35.
• Eibes G, Santos F, Andrade PZ, Boura JS, Abecasis MM, Silva CL,
Cabral JS. Maximizing the ex vivo expansion of human
mesenchymal stem cells using a microcarrier-based stirred culture
system. J Biotechnology 2010, 146: 194
• Santos, F, Andrade PZ, Boura JS, Abecasis MM, Silva CL, Cabral
JS. Ex vivo expansion of human mesenchymal stem cells: a more
effective cell proliferation kinetics and metabolism under hypoxia. J
Cell Physiology 2010, 223: 27.
• Cordonnier C, Rovira M, Maertens J, Olavarria E, Faucher C, Bilger
K, Pigneux A, Cornely OA, Ullmann AJ, Martino Bofarull R, de la
Camara R, Weisser M, Liakopoulou E, Abecasis M.Heussel
CP, Pineau M, Ljungman P, Einsele H. Voriconazole for secondary
prophylaxis of invasive fungal infection in allogeneic stem cell
transplant recipients: results of the VOSIFI study.
Haematologica 2010 , 95: 1762
• Nabhan SK, Bitencourt M, Duval M, Abecasis M, Dufour C, Boudjedir
K, Rocha V, Socie' G, Passweg J, Goi K, Sanders J, Snowden
J, Yabe H, Pasquini R, Gluckman E. Fertility recovery and pregnancy
after allogeneic hematopoietic stem cell transplantation in Fanconi
anemia patients. Haematologica 2010 , 95: 1783
• L Silva R, Ferreira I, Teixeira G, Cordeiro D, Mafra M, Costa I, JM
Bravo Marques, Abecasis M.BK vírus encephalitis with thrombotic
microangiopathy in a allogeneic hematopoietic stem cell recipient.
Transpl Infect Dis 2011, 13: 161
• Bizzetto R, Bonfim C, Abecasis M.,Rocha V, Socié G, Locatelli F,
Chan K, Ramirez O, Stein J, Nabhan S, Miranda E, Passweg J, de
Souza CA, Gluckman E; Eurocord and SAA-WP from EBMT
Outcomes after related and unrelated umbilical cord blood
transplantation for hereditary bone marrow failure syndromes other
than Fanconi anemia. Haematologica 2011, 96: 134
7
• Marks DI, Pagliuca A, Abecasis M.,Kibbler CC, Glasmacher A,
Heussel CP, Kantecki M, Miller PJ, Ribaud P, Schlamm HT, Solano
C, Cook G; IMPROVIT Study Group. Voriconazole versus
itraconazole for antifungal prophylaxis following allogeneic
haematopoietic stem-cell transplantation. Br J Haematol 2011, 155:
318
• Ljungman P, de la Camara R, Perez-Bercoff L, Abecasis M, Nieto
Campuzano JB, Cannata-Ortiz MJ, Cordonnier C, Einsele H,
Gonzalez-Vicent M, Espigado I, Halter J, Martino R, Mohty B, Sucak
G, Ullmann AJ, Vázquez L, Ward KN, Engelhard D; Infectious
Diseases Working Party, European Group for Blood and Marrow
Transplantation; Infectious Complications Subcommittee, Spanish
Group of Haematopoietic Stem-cell Transplantation. Outcome of
pandemic H1N1 infections in hematopoietic stem cell transplant
recipients. Haematologica 2011, 96: 1231
• Santos Fd, Andrade PZ, Abecasis MM, Gimble JM, Chase LG,
Campbell AM, Boucher S, Vemuri MC, Silva CL, Cabral JM. Toward
a clinical-grade expansion of mesenchymal stem cells from human
sources: a microcarrier-based culture system under xeno-free
conditions. Tissue Eng Part C Methods 2011, 17: 1201
• Brito M, Sanchez P, Velho S, Miranda N, Leal da Costa F, Ferreira I,
Teixeira G, Guimarães A, Abecasis M,Passos Coelho JL. High dose
chemotherapy with autologous stem-cell support in germ cell tumors:
The Instituto Português de Oncologia de Lisboa Francisco Gentil.
Acta Med Port 2011, 24: 533